AG真人官方

STOCK TITAN
  1. Home
  2. Sec-filings
  3. THTX
  4. [6-K] Theratechnologies Inc. Common Current Report (Foreign Issuer)

[6-K] Theratechnologies Inc. Common Current Report (Foreign Issuer)

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
6-K

Filing content is currently unavailable.

Source:

Stock THTX logo
Theratechnologies Inc

NASDAQ:THTX

THTX Rankings

#4456 Ranked by Market Cap
N/A Ranked by Dividends

THTX Latest News

Sep 12, 2025
Theratechnologies Shareholders Approve Proposed Plan聽of聽Arrangement聽to聽Be聽Acquired聽by聽Future Pak
Sep 5, 2025
Theratechnologies Announces Availability of EGRIFTA WR鈩� (tesamorelin) for injection to Reduce Excess Abdominal Fat in Adults with HIV and Lipodystrophy
Aug 18, 2025
Theratechnologies Announces Filing of Special Meeting Materials and Receipt of Interim Order in Relation to its Acquisition by CB Biotechnology, an Affiliate of Future聽Pak
Jul 9, 2025
Theratechnologies Reports Financial Results聽for the Second Quarter 2025
Jul 3, 2025
Theratechnologies to Announce Second Quarter 2025 Financial Results

THTX Latest SEC Filings

Sep 5, 2025
[6-K] Theratechnologies Inc. Common Current Report (Foreign Issuer)
Sep 2, 2025
[6-K] Theratechnologies Inc. Common Current Report (Foreign Issuer)
Aug 18, 2025
[6-K] Theratechnologies Inc. Common Current Report (Foreign Issuer)
Aug 18, 2025
[6-K] Theratechnologies Inc. Common Current Report (Foreign Issuer)
Aug 5, 2025
[SCHEDULE 13G/A] Theratechnologies Inc. Common SEC Filing

THTX Stock Data

150.35M
34.79M
1.15%
45.49%
0.46%
Biotechnology
Healthcare
Canada
Montreal